BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 19518054)

  • 1. Characterization of protein impurities and site-specific modifications using peptide mapping with liquid chromatography and data independent acquisition mass spectrometry.
    Xie H; Gilar M; Gebler JC
    Anal Chem; 2009 Jul; 81(14):5699-708. PubMed ID: 19518054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an integrated MS--multiplexed MS/MS data acquisition strategy for high-coverage peptide mapping studies.
    Chakraborty AB; Berger SJ; Gebler JC
    Rapid Commun Mass Spectrom; 2007; 21(5):730-44. PubMed ID: 17279597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS.
    Geromanos SJ; Vissers JP; Silva JC; Dorschel CA; Li GZ; Gorenstein MV; Bateman RH; Langridge JI
    Proteomics; 2009 Mar; 9(6):1683-95. PubMed ID: 19294628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.
    Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ
    J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of glycosylation sites for a recombinant IgG1 monoclonal antibody and a CTLA4-Ig fusion protein by liquid chromatography-mass spectrometry peptide mapping.
    Bongers J; Devincentis J; Fu J; Huang P; Kirkley DH; Leister K; Liu P; Ludwig R; Rumney K; Tao L; Wu W; Russell RJ
    J Chromatogr A; 2011 Nov; 1218(45):8140-9. PubMed ID: 21978954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of peptide mapping with electrospray mass spectrometry for recombinant proteins of biopharmaceutical interest and its applications as an identity test and a characterization tool.
    Wei Z; Tous G; Yim A; Hope JN; Casas-Finet JR; Folena-Wasserman G; Schenerman MA
    Dev Biol (Basel); 2005; 122():29-47. PubMed ID: 16375249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of enzymatic digestion and liquid chromatography-mass spectrometry peptide mapping of the integral membrane protein bacteriorhodopsin.
    Hixson KK; Rodriguez N; Camp DG; Strittmatter EF; Lipton MS; Smith RD
    Electrophoresis; 2002 Sep; 23(18):3224-32. PubMed ID: 12298094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein identification by peptide mass fingerprinting and peptide sequence tagging with alternating scans of nano-liquid chromatography/infrared multiphoton dissociation Fourier transform ion cyclotron resonance mass spectrometry.
    Kosaka T; Yoneyama-Takazawa T; Kubota K; Matsuoka T; Sato I; Sasaki T; Tanaka Y
    J Mass Spectrom; 2003 Dec; 38(12):1281-7. PubMed ID: 14696210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping site-specific protein N-glycosylations through liquid chromatography/mass spectrometry and targeted tandem mass spectrometry.
    Wu Y; Mechref Y; Klouckova I; Mayampurath A; Novotny MV; Tang H
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):965-72. PubMed ID: 20209665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Method to site-specifically identify and quantitate carbonyl end products of protein oxidation using oxidation-dependent element coded affinity tags (O-ECAT) and nanoliquid chromatography Fourier transform mass spectrometry.
    Lee S; Young NL; Whetstone PA; Cheal SM; Benner WH; Lebrilla CB; Meares CF
    J Proteome Res; 2006 Mar; 5(3):539-47. PubMed ID: 16512668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping posttranslational modifications of proteins by MS-based selective detection: application to phosphoproteomics.
    Carr SA; Annan RS; Huddleston MJ
    Methods Enzymol; 2005; 405():82-115. PubMed ID: 16413312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of monoclonal antibody product heterogeneity resulting from alternate cleavage sites of signal peptide.
    Kotia RB; Raghani AR
    Anal Biochem; 2010 Apr; 399(2):190-5. PubMed ID: 20074542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications.
    Delporte C; Van Antwerpen P; Zouaoui Boudjeltia K; Noyon C; Abts F; Métral F; Vanhamme L; Reyé F; Rousseau A; Vanhaeverbeek M; Ducobu J; Nève J
    Anal Biochem; 2011 Apr; 411(1):129-38. PubMed ID: 21129357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated mass correction and data interpretation for protein open-access liquid chromatography-mass spectrometry.
    Wagner CD; Hall JT; White WL; Miller LA; Williams JD
    J Mass Spectrom; 2007 Feb; 42(2):139-49. PubMed ID: 17221927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic LC-MS analysis of labile post-translational modifications in complex mixtures.
    Carapito C; Klemm C; Aebersold R; Domon B
    J Proteome Res; 2009 May; 8(5):2608-14. PubMed ID: 19284785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human liver diacetyl reductases by nano-liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry.
    Tanaka Y; Sato I; Iwai C; Kosaka T; Ikeda T; Nakamura T
    Anal Biochem; 2001 Jun; 293(2):157-68. PubMed ID: 11399028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified peptide mapping strategy for quantifying site-specific deamidation by electrospray time-of-flight mass spectrometry.
    Stroop SD
    Rapid Commun Mass Spectrom; 2007; 21(6):830-6. PubMed ID: 17294517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale identification and quantification of covalent modifications in therapeutic proteins.
    Zhang Z
    Anal Chem; 2009 Oct; 81(20):8354-64. PubMed ID: 19764700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional region identification in proteins by accumulative-quantitative peptide mapping using RP-HPLC-MS.
    Kuipers BJ; Bakx EJ; Gruppen H
    J Agric Food Chem; 2007 Nov; 55(23):9337-44. PubMed ID: 17944536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals.
    Srebalus Barnes CA; Lim A
    Mass Spectrom Rev; 2007; 26(3):370-88. PubMed ID: 17410555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.